STAT+: Psilocybin data could be good enough for approval
Stat News • 2/10/2026 – 2/17/2026
Summary
No summary yet.
Advertisement
Cluster Activity
3
8
2
1
1
2026-02-102026-02-17
Lindy Score Breakdown (V4.2)
3h
Age
7
Sources
from cluster
3
Hours Since Seen
Final Score48/100
CategoryLindy
StatusActive
Recency Multiplier96% (0.5^3/48)
Hero EligibleYes
Story Timeline
- 2026-02-10
- 2026-02-11
- 2026-02-12
- 2026-02-13
- 2026-02-17STAT+: Psilocybin data could be good enough for approval (current)
Score BreakdownRisk 45
Source Reputation: Low-trust source (4/20 pts)
Consensus: Strong consensus: 7 independent sources
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 11 sources
STAT+: Pediatricians confront HHS in vaccine showdown
Stat News • 4 days ago
STAT+: A change at the top of Sanofi
Stat News • 5 days ago
STAT+: Pharmalittle: We’re reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and more
Stat News • 5 days ago
FDA officials defend decision to not review Moderna’s new flu vaccine
The Boston Globe • 5 days ago
STAT+: Prasad overruled FDA staff to reject Moderna’s flu vaccine application
Stat News • 6 days ago
STAT+: The unusual Prasad missive in the FDA’s rejection of the Moderna flu shot application
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about FDA rejecting a Moderna vaccine, compounding in the crosshairs and more
Stat News • 6 days ago
FDA refuses to review Moderna’s mRNA flu vaccine application
Fox News • 6 days ago
FDA won’t review Moderna’s application for first mRNA-based flu vaccine
The Washington Post • 6 days ago
FDA refuses to review Moderna's mRNA flu vaccine
Ars Technica • 6 days ago
Breaking Similar stories
STAT+: Does Medicare’s ACCESS model pay enough?
Stat News • Today
STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials
Stat News • Today
STAT+: In a financial pinch, major health insurers are turning to AI for help
Stat News • Today
STAT+: Exit of CDC’s acting director highlights agency’s lack of leader
Stat News • 2 days ago
STAT+: As China’s drug industry races ahead, its GLP-1 race is accelerating too
Stat News • Today
STAT+: Kennedy says he’ll act on legal challenge to ultra-processed foods
Stat News • 1 day ago
STAT+: Medicare Advantage growth dwindles for a second straight year
Stat News • 1 day ago
STAT+: Breakup between Brigham and Dana-Farber is getting messier fast
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about China’s homegrown GLP-1 drugs, a puzzling FDA rejection, and more
Stat News • Today
STAT+: Ocular’s experimental eye drug beats low dose of Regeneron’s Eylea in late-stage trial
Stat News • Today
Anti-Lindy Similar stories
STAT+: Prasad overruled FDA staff to reject Moderna’s flu vaccine application
Stat News • 6 days ago
STAT+: FDA refuses to review Moderna’s influenza vaccine
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about FDA rejecting a Moderna vaccine, compounding in the crosshairs and more
Stat News • 6 days ago
STAT+: A change at the top of Sanofi
Stat News • 5 days ago
STAT+: The unusual Prasad missive in the FDA’s rejection of the Moderna flu shot application
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and more
Stat News • 5 days ago
STAT+: Pediatricians confront HHS in vaccine showdown
Stat News • 4 days ago